ERBB2 and breast cancer: This prospective clinical study was designed to assess the potential added value of hyperpolarized 13C-MRI for very early response assessment in patients with aggressive breast cancer (TNBC or HER2+) undergoing neoadjuvant treatment in comparison with advanced multiparametric proton MRI techniques.